7:01 am ISIS Pharm reports interim results from ISIS-SMN Rx multiple dose study in children with spinal muscular atrophy; average increase of 3.7 points observed in muscle function score in SMA children treated with 9 mg of ISIS-SMN Rx; on
View todays social media effects on ISIS
View the latest stocks trending across Twitter. Click to view dashboard
See who Isis is hiring next, click here to view
